University of Baghdad Launches Ivermectin Clinical Trial for COVID-19 Patients https://t.co/NaFxVGTOsJ
— EZEQUIEL JETHMAL (@EZEQUIELJETHMAL) May 5, 2020
#Australia
— ALÓ FERTILIZANTES (@AloFertilizante) April 7, 2020
The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Autores
Leon Caly
Victorian Infectious Diseases Laboratory
Royal Melbourne Hospital
Kylie M. Wagstaff
Biomedicine Institute,
Monash University
Cc@AlvaradoC_MPPShttps://t.co/AH23EUBoxi